A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Pancreatic cancer has one of the highest mortality rates among cancers, and a combination of nab-paclitaxel with gemcitabine remains the cornerstone of first-line therapy. However, major advances are required to achieve improvements in patient outcomes. For this reason, several research groups have...
Na minha lista:
Autor principal: | |
---|---|
Outros Autores: | , , , |
Formato: | Artículo |
Idioma: | en_US |
Publicado em: |
2022
|
Assuntos: | |
Acesso em linha: | https://doi.org/10.3390/life12030327 https://www.mdpi.com/2075-1729/12/3/327/htm |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Seja o primeiro a deixar um comentário!